Blog
Preparing for the Inflation Reduction Act - Part 1: What is the IRA and why should you care?
In this first part of a three-part series Emma Tinsley, Chief Executive Officer of Weatherden explains what the IRA is, how it affects drug pricing, and why biotech and pharma companies – including those outside the US – need to take notice.
>200 companies
We have advised, worked with and supported dozens of funds and biotechs.
>500 million plus
Our input is benefitting patient populations worldwide.
>25 billion USD
Our repeat and long-term clients have realised significant value gains since we became involved in their programmes.